Results
- Showing results for:
- Reset all filters
Search results
-
Journal articleRegamey N, Ochs M, Hilliard TN, et al., 2007,
Airway smooth muscle remodeling in children with cystic fibrosis
, PEDIATRIC PULMONOLOGY, Pages: 349-350, ISSN: 8755-6863 -
Journal articleVerdejo R, Lamoriniere S, Cottam B, et al., 2007,
Removal of oxidation debris from multi-walled carbon nanotubes
, CHEMICAL COMMUNICATIONS, Pages: 513-515, ISSN: 1359-7345- Author Web Link
- Cite
- Citations: 176
-
Journal articleHorsley A, Macleod K, Saunders C, et al., 2007,
UKCF gene therapy consortium tracking study: Lung clearance index improves with treatment of an infective exacerbation
, PEDIATRIC PULMONOLOGY, Pages: 335-336, ISSN: 8755-6863- Author Web Link
- Cite
- Citations: 3
-
Journal articleDavies J, Voase N, Dewar M, et al., 2007,
UKCF Gene Therapy Consortium tracking study: Response of clinically-available assays to intravenous antibiotics
, PEDIATRIC PULMONOLOGY, Pages: 347-347, ISSN: 8755-6863 -
Journal articleGriesenbach U, Jeswiet SB, Larsen MD, et al., 2007,
UKCF gene therapy consortium tracking study: Change in sputum properties in response to IV antibiotic
, PEDIATRIC PULMONOLOGY, Pages: 229-229, ISSN: 8755-6863 -
Conference paperRyall B, Davies JC, Wilson R, et al., 2007,
Cyanide accumulates in the sputum of Pseudomonas aeruginosa-infected cystic fibrosis and non-cystic, fibrosis bronchiectasis patients and is associated with impaired lung function
, Publisher: WILEY-LISS, Pages: 327-327, ISSN: 8755-6863 -
Journal articleMacleod K, Horsley A, Gray R, et al., 2007,
UK cystic fibrosis gene therapy consortium tracking study: Exhaled breath condensate pH increases with treatment of an infective exacerbation
, PEDIATRIC PULMONOLOGY, Pages: 343-344, ISSN: 8755-6863 -
Book chapterAlton EWFW, Davies JC, Geddes DM, 2006,
Gene therapy for lung diseases
, Principles of Molecular Medicine, Pages: 259-268Gene therapy is under development for a variety of lung disease, both those caused by single gene defects, such as cystic fibrosis and α1- antitrypsin deficiency, and multifactorial diseases such as cancer, asthma, lung fibrosis, and ARDS. Both viral and nonviral approaches have been explored, the major limitation to the former being the inability to repeatedly administer, which renders this approach perhaps more applicable to conditions requiring single administration, such as cancer. Progress in development and clinical trials in each of these diseases is reviewed, together with some potential newer approaches for the future. © 2006 Humana Press Inc.
-
Conference paperWort SJ, McMaster S, Mitchell JA, et al., 2006,
Acetylation of histone H4 at NF-ΚB sites on pre-pro ET-1 promoter is involved in synergistic synthesis of ET-1 in human pulmonary artery smooth muscle cells treated with TNF-α and IFN-γ
, Winter Meeting of the British-Thoracic-Society/British-Lung-Foundation (BTS/BLF), Publisher: B M J PUBLISHING GROUP, Pages: II19-II19, ISSN: 0040-6376 -
Journal articleHoyles RK, Ellis RW, Wellsbury J, et al., 2006,
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
, ARTHRITIS AND RHEUMATISM, Vol: 54, Pages: 3962-3970, ISSN: 0004-3591- Author Web Link
- Cite
- Citations: 487
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.
General enquiries
For any enquiries about the Fungal Science Network at Imperial, please contact: